| | 2469-34-3 Basic information More.. |
| Product Name: | SENEGENIN | | Synonyms: | SENEGENIN;SENEGIN;28-dioicacid,12-(chloromethyl)-2-beta,3-beta-dihydroxy-27-noro-13-ene-2;27-Norolean-13-ene-23,28-dioicacid, 12-(chloromethyl)-2,3-dihydroxy-, (2β,3β,4α,12α)-;Tenuigenin;12α-(Chloromethyl)-2β,3β-dihydroxy-27-nor-5α-olean-13-ene-23,28-dioic acid;12α-Chloromethyl-2β,3β-dihydroxy-27-norolean-1-ene-23,28-dioic acid;Tenuifolic acid | | CAS: | 2469-34-3 | | MF: | C30H45ClO6 | | MW: | 537.13 | | EINECS: | | | Mol File: | 2469-34-3.mol |  |
- SENEGENIN
-
- US $0.00 / kg
- 2024-04-12
- CAS:2469-34-3
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
- Senegenin
-
- US $0.00 / mg
- 2023-02-24
- CAS:2469-34-3
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- Senegenin
-
- US $0.00 / mg
- 2023-02-24
- CAS:2469-34-3
- Min. Order: 5mg
- Purity: Analytical Standard
- Supply Ability: 10 g
|
|
2469-34-3
Recommend Suppliers |
| Company Name: |
Hubei Jusheng Technology Co.,Ltd.
Recommend
Complaint |
 |
| Tel: |
18871490254 |
| FAX: |
027-59599243 |
| Email: |
linda@hubeijusheng.com |
| Nationality: |
CHINA |
| Products Intro: |
Product Name:13-(chloromethyl)-2,3-dihydroxy-4,6a,11,11,14b-pentamethyl-2,3,4a,5,6,7,8,9,10,12,12a,13,14,14a-tetradecahydro-1H-picene-4,8a-dicarboxylic acid CAS:2469-34-3 Purity:99% Package:5KG;1KG |
| CB Index: |
58 |
| WebSite: |
www.hubeijusheng.com |
| Related Information: |
Sales Network
Catalog(28172)
User Evaluation
|
|
|
|
|
| Company Name: |
Labnetwork lnc.
Recommend
Complaint |
 |
| Tel: |
+86-27-50766799 |
| FAX: |
|
| Email: |
contact@labnetwork.com |
| Nationality: |
China |
| Products Intro: |
Product Name:(2S,3R,4S,4aR,6aR,8aS,12aS,13S,14aR,14bR)-13-(chloromethyl)-2,3-dihydroxy-4,6a,11,11,14b-pentamethyl-2,3,4a,5,6,7,8,9,10,12,12a,13,14,14a-tetradecahydro-1H-picene-4,8a-dicarboxylic acid CAS:2469-34-3 Purity:95% Package:100g; 1kg Remarks:LN01312757 |
| CB Index: |
58 |
| WebSite: |
www.labnetwork.com |
| Related Information: |
Sales Network
Catalog(19987)
User Evaluation
|
|
|
|
|
|